Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Large B-Cell, Diffuse × Everolimus × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 16 Carcinoma, Renal Cell 10 Neuroendocrine Tumors 8 Neoplasm Metastasis 8 Recurrence 5 Endometrial Neoplasms 4 Tuberous Sclerosis 3 Neoplasms 3 Glioma 3 Glioblastoma 3 von Hippel-Lindau Disease 2 Triple Negative Breast Neoplasms 2 Skin Neoplasms 2 Sarcoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Meningioma 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Kidney Neoplasms 2 Gastro-enteropancreatic neuroendocrine tumor 2 Diffuse Intrinsic Pontine Glioma 2 Carcinoma, Hepatocellular 2 Brain Neoplasms 2 Adenoma, Islet Cell 2 Waldenstrom Macroglobulinemia 1 Vascular Malformations 1 Thyroid cancer, Hurthle cell 1 Thyroid Neoplasms 1 Thyroid Diseases 1 Thymus Neoplasms 1 Seizures 1

Interventions

Cyclophosphamide 80 Rituximab 77 Prednisone 45 Doxorubicin 39 Lenalidomide 35 Vincristine 32 fludarabine 27 polatuzumab vedotin 25 Magnetic Resonance Spectroscopy 24 Gemcitabine 23 Etoposide 23 Specimen Handling 22 Oxaliplatin 19 Biopsy 18 CT-P10 17 glofitamab 15 zanubrutinib 14 ibrutinib 13 fludarabine phosphate 13 tafasitamab 12 obinutuzumab 12 axicabtagene ciloleucel 12 venetoclax 10 pembrolizumab 10 deltacortene 10 Bendamustine Hydrochloride 10 prednylidene 9 Prednisolone 9 Nivolumab 9 Immunotherapy, Adoptive 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡